Literature DB >> 33593837

Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany.

Roger Dumke1.   

Abstract

Ureaplasma urealyticum and U parvum are mollicutes species that colonize the urogenital tract of many asymptomatic persons but are also thought to be associated with symptomatic infections. Using 170 strains isolated between 2016 and 2019 in a German university hospital, resistance was tested by a combination of commercial tests, molecular methods and determination of minimal inhibitory concentrations. Rates of resistance to macrolides, tetracyclines and fluoroquinolones were 0%, 4.1% and 7.1%, respectively.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33593837      PMCID: PMC8092870          DOI: 10.1128/AAC.02342-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

Review 2.  Antibiotic resistance among Ureaplasma spp. isolates: cause for concern?

Authors:  M L Beeton; O B Spiller
Journal:  J Antimicrob Chemother       Date:  2016-10-20       Impact factor: 5.790

3.  In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.

Authors:  C M Bebear; H Renaudin; A Charron; D Gruson; M Lefrancois; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 4.  The Role of Ureaplasma spp. in the Development of Nongonococcal Urethritis and Infertility among Men.

Authors:  Michael L Beeton; Matthew S Payne; Lucy Jones
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

Review 5.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.

Authors:  Jingjuan Song; Yingli Qiao; Yingying Kong; Zhi Ruan; Jun Huang; Tiejun Song; Jun Zhang; Xinyou Xie
Journal:  J Med Microbiol       Date:  2015-08-04       Impact factor: 2.472

8.  Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.

Authors:  Michael L Beeton; Victoria J Chalker; Lucy C Jones; Nicola C Maxwell; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

9.  Spread of multidrug resistance among Ureaplasma serovars, Tunisia.

Authors:  Safa Boujemaa; Béhija Mlik; Amina Ben Allaya; Helmi Mardassi; Boutheina Ben Abdelmoumen Mardassi
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-23       Impact factor: 4.887

10.  Prevalence and Antimicrobial Susceptibility of Mycoplasma hominis and Ureaplasma Species in Nonpregnant Female Patients in South Korea Indicate an Increasing Trend of Pristinamycin-Resistant Isolates.

Authors:  Ji Yong Lee; Jeong Seon Yang
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more
  1 in total

1.  Antimicrobial susceptibilities and mechanisms of resistance of commensal and invasive Mycoplasma salivarium isolates.

Authors:  Li Xiao; Arthur H Totten; Donna M Crabb; Thomas Prescott Atkinson; Ken B Waites
Journal:  Front Microbiol       Date:  2022-08-01       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.